Exchange: NASDAQ·Updated 04:00 PM EDT
DCGO logo

DCGO DocGo Inc

$0.2731
$0.0068
(2.43%)
Today
EarningsNov 9
Mkt Cap$27.03M
Vol681,448.00

About DCGO

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.
47

Neutral Sentiment

How do you feel about DCGO?

Logic102
$DCGO After talking with IR, NYC owes DCGO almost $13 M which might get negotiated down to approximately 9 M and the NY Dept of Human Services had been radio silent about a $6 M debt until recently and have acknowledged recently that they owe this and will pay this. Also, DCGO is winding down a losing Upstate NY ambulance business which has been an annual 3 M loss of EBITA. When they sell the license and some other assets to Northwell they should get approximately 3.5 M and this will improve the Gross Margin of the overall business to about 31.5%. Hopefully, all of this gets done by year end or very early 2027. Look at the Market Cap in light of just this information. No Brainer Buy
5
buyabdholder
$DCGO people forget they $60 million in cash from accounts receivable that drips in from commercial payers.
1
2
amda
$DCGO this would still be cheap at 5X the current price. the market will wake up to this hidden gem sooner or later.....
3
amda
$DCGO revenue run rate almost $300MM; current market cap $27MM; sure, the acquisition muddies the picture a little (enhances the long term prospects though), but this valuation is absolutely ridiculous
3
amda
$DCGO DocGo remains on track to exit fiscal year 2026 with positive adjusted EBITDA in its core business. Needham stated the risk/reward profile remains attractive for DocGo shares at current levels. InvestingPro analysis suggests the stock is undervalued based on its Fair Value assessment, with the company appearing on the platform’s most undervalued stocks screening. The firm maintained its $3.00 price target on the stock.
1
1
jamescinv
$DCGO the difference between me and you homer is your a trader and im a investor. I will win in the long run. You lose. Same thing with CGC last year😉
1
1
Logic102
$DCGO What we will likely see in coming weeks and months: money coming in from NYC, the sale of the Upstate NY ambulance business, other "right sizing" adjustments which I believe will include the sale of the UK business since it's no longer a good fit with the long-term business model. If the share price remains below 40 cents, we will hopefully see a stock buyback Program emerge. What we don't want to see is the C Suite awarding themselves a lot of shares at these depressed prices. The last quarter earnings will likely be "meh" but we need to see the turn around emerging in the next Quarter. The M Cap remains stupidly low, hence, Outstanding Risk Reward Buy.
2
gerson999
$DCGO can you say "sold out"? now comes fomo? 30 cent will be looked back with fondness soon?
3
buyabdholder
$DCGO CEO Lee Bienstock has maintained explicit guidance that DocGo will exit Q4 2026 at a profitable Adjusted EBITDA run rate. Because profitability is reached during the quarter rather than on day one, a minor net cash burn remains for the full three-month period. Q1 2027: Self-Sustaining Structure (Projected Burn: $0 — Turning FCF Positive) • The Driver: Q1 2027 is the first clean quarter entirely disconnected from the legacy migrant program liabilities and overhead. • The Math: The cash burn is modeled to cross the zero line completely. DocGo's new automated routing systems and corporate downsizing are projected to reach their scale efficiencies of $20 million to $24 million in annualized savings by early 2027. • The Catalyst: High-margin revenues from the fully integrated Hicuity Health acquisition and the seasonal acceleration of SteadyMD's virtual care business layer over the stabilized core ambulance fleet, pushing the total entity into a self-funding loop.
1
buyabdholder
$DCGO novavax up 20% today, Moderna 6%. Who is in position to deliver vaccines and antibiotics to an aging population that is vulnerable to the pneumonic plague? Certainly DocGo….
3
Logic102
$DCGO 27.9 cents 28.24M Market Cap are just ridiculously cheap for a company with such assets, primed to break even and begin a major growth trend.
2
Nuclear_Elvis
$DCGO The thing about the Hicuity "Deal" that doesn't sit well with me is this -- forcing a Restricted Cash situation on the company, that did not have one before the Deal, AND using DocGo cash to pay all of Hicuity's expenses to include Golden Parachutes, before the Deal closes, means DocGo's Cash Position is both Weakened and Restricted, in the face of New Debt and merged operations. Guess What? That legally enhances all the C-Suite positions to garner more "Stock in lieu of Cash" Salary payments, here at the All-Time low trading level of the stock. So, all the C-Suite can choose to take outsized portions of their salary, as Stock instead, arguably beyond the levels they did before, because again - the "Cash Position" is so weakened now. Is this what the CFO is actually good at? Manipulating the books and situation? Because that's how this is starting to appear for us shareholders outside-looking-in, and is why I keep saying that of all the C-Suite, the CFO is the one to fire first.
1
gerson999
$DCGO is there any price where this is a value? how about 10 cents, or a nickel? Do you sell at 20 cents or 50 cents. What if the price goes to 1.15 Monday? The point is that there is a reason to buy or sell any stock. Can you estimate future earnings and cash flows? Estimated revenues for 2027=$375 million. Can the businesses generate a profit? Ambulance, critical care (ICU), patient monitoring, telehealth, home visits, and care gap. all either operating at scale or approaching positive cash flows. The recent stock price collapse is a simple loss of confidence in management. WELL DESERVED! But if there is no major fraud (we should have seen something by now?,) this stock looks classically washed out.
2
gerson999
$DCGO there is a reason management is quiet... they are idiots and have no business running a public company. i am part of the buying today. low price equals value
2
HealthcareGuru1855
$DCGO I really need to start taking screenshots of this board. In two years when all of us who averaged in here are staring at a $5-10 share price I’ll look back and laugh. They will exit 2026 with a profitable run rate, build back slowly in 2027 (reverse split or not who cares it doesn’t dilute) and then come 2028 when the markets values this and the company is growing the hicuity deal will be praised, and we all will make money…except the day traders thinking of today. Hold fast. Hold strong.
2
aamis
$DCGO technically, the daily chart is looking goooood. We have a presumable ATL and now NH. We need to next confirm HL and afterwards HH for a bullish trend change. Stay strong. It might be that we are still building NH.
2
Nuclear_Elvis
$DCGO Fire the CFO. Warn the CEO that he's next if he doesn't produce results in the next year.
1
TheOriginalBagHolder
$DCGO I ask the bagholders here, I mean everybody here: aren't you upset, at least a little, by the useless CEO's performance? Aren't you upset about having to force yourselves to believe the "future growth" bs everyday? Aren't you upset about having to pretend you are "investors" and not trapped traders? Even , who as far as I know could be anything from buyer to shorter and a bagholder like us, is at least expressing his view on the CFO. Nobody else has an honest opinion apart from the wishful thinking bs?
TheOriginalBagHolder
$DCGO This POS reminds me of $TTOO . I know $TTOO was never profitable, not even once (well, they didn't "win" a $432M no-bid contract to make up the numbers either), but anyway never turned a profit. However they had great technology that never really catched on although it was FDA-approved. A million reverse splits to keep milking shareholders. Then OTC-cemetery. It shows you can have good technology (life-saving technology in the case of $TTOO ) . Having great technology allows you to make up a beautiful narrative IF/WHEN the Market realizes its potential and keep on living off that "future" to come. Not the same but I remembered that. I never bought $TTOO , but I bought $THMO , another "life-saving" technology that would save the world. Another reverse split machine sent to the OTC cemetery.
TheOriginalBagHolder
$DCGO Guys, we are looking at the wrong picture here. It's not that $DCGO has fallen a whopping -97.22% since inception. It's that it has NOT fallen 2.78% 💪💪💪 Amazing value here. I mean amazing narrative/fairy tale. 🤡🤡🤡

Advertisement|Remove ads.